*As of April 19, 2023, based on publicly available resources
† For the purposes of refractive correction, the lenses are indicated for reducing refractive error up to 4.00D (sphere product) and up to 5.00D and up to 3.50D of astigmatism (toric product). Results may vary by patient and prescription level.
‡ Compared to single-vision spectacles. Generally speaking, 0.18mm corresponds to approximately 0.05D of myopia control
# Final lens fit is determined by the ECP – software is for decision support only
^ In children, with-the-rule astigmatism is the predominant type of astigmatism.
** Study included patients with astigmatism of up to 2.75D.
References
1. Data on File 2023. Instruction for Use (Canada)
2. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci [Internet]. 2012/09/13. 2012;53(11):7077–85.
3. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Myopia control with orthokeratology contact lenses in Spain: Refractive and biometric changes. Invest Ophthalmol Vis Sci. 2012;53(8).
4. Chen C, Cheung SW, Cho P. Myopia control using toric orthokeratology (TO-SEE study). Invest Ophthalmol Vis Sci [Internet]. 2013/09/05. 2013;54(10):6510–7.
5. Walline JJ, Robboy MW, Hilmantel G, Tarver ME, Afshari NA, Dhaliwal DK, Morse CL, Quinn CJ, Repka MX, Eydelman MB. Food and Drug Administration, American Academy of Ophthalmology, American Academy of Optometry, American Association for Pediatric Ophthalmology and Strabismus, American Optometric Association, American Society of Cataract and Refractive Surgery, and Contact Lens Association of Ophthalmologists Co-Sponsored Workshop: Controlling the Progression of Myopia: Contact Lenses and Future Medical Devices. Eye Contact Lens. 2018 Jul;44(4):205-211
6. Wan K, Lau JK kit, Cheung SW, Cho P. Refractive and corneal responses of young myopic children to short-term orthokeratology treatment with different compression factors. Contact Lens Anterior Eye. 2020;43(1):65-72.
7. Chan KY, Cheung SW, Cho P. Clinical performance of an orthokeratology lens fitted with the aid of a computer software in Chinese children. Cont Lens Anterior Eye [Internet]. 2012/03/07. 2012;35(4):180–4
8. Data on File 2023. Menicon Design History file
9. Data on File 2023. Menicon Internal Documentation
10. Lau JK, Vincent SJ, Cheung SW, Cho P. Higher-order aberrations and axial elongation in myopic children treated with orthokeratology. Investig Ophthalmol Vis Sci. 2020;61(2).
11. Chen CC, Cheung SW, Cho P. Toric orthokeratology for highly astigmatic children. Optom Vis Sci [Internet]. 2012/05/09. 2012;89(6):849–55.
12. Dobson V, Dobson V, Fulton AB, Sebris SL. Invest Ophthalmol Vis Sci. 1984 Jan;25(1):83-7.
13. Yu-Hung Lai 1, Hsin-Tien Hsu, Hwei-Zu Wang, Cheng-Hsien Chang, Shun-Jen Chang PMID: 20451858 DOI: 10.1016/j.jaapos.2009.12.168
14. Santodomingo-Rubido J, Villa-Collar C, Gilmartin B, Gutiérrez-Ortega R. Myopia Control With Orthokeratology Contact Lenses in Spain: A Comparison of Vision-Related Quality-of-Life Measures Between Orthokeratology Contact Lenses and Single-Vision Spectacles. Eye & Contact Lens 2013; Volume 39, Number 2.
15. JJV Data on File 2021. Development of Optical Design of ACUVUE® AbilitiTM 1-Day Soft Therapeutic Lenses for Myopia Management.
Important safety information:
ACUVUE® AbilitiTM Overnight Therapeutic (tisilfocon A) Contact Lenses are indicated for use in the control of myopia. They are indicated for overnight wear for the temporary reduction of myopia and should only be disinfected using a chemical disinfection system. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness, other eye problems, or if patients have any allergy to any ingredient in a solution which is to be used to care for these lenses. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-877-334-3937, option 4, or by visiting www.seeyourabiliti.com.
Important Safety information:
Acuvue® AbilitiTM 1-Day Soft Therapeutic Lenses for Myopia Management are available by prescription only for the correction of myopia (while the lenses are worn) and may slow the progression of myopia in children (7-12 years old). As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. These lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness, other eye problems. Due to the intended optical design of these lenses for the purpose of reducing the patient’s prescription change, these lenses will provide vision correction while worn, but the vision quality may not be as clear as with conventional soft contact lenses. Patients should exercise extra care if performing potentially hazardous, vision demanding activities. Complete information is also available from Johnson & Johnson Vision Care, Inc. by calling 1-877-334-3937, option 4, or visit www.seeyourabiliti.com.
PP2023ABLM4115
